Step Therapy If the patient doesnt have cardiovascular or chronic kidney disease, they can go through a process called step therapytrying certain alternatives first, and moving on to Ozempic if they dont work
Maturity Gap: Phase 3 Belongs to Injectables Our phase distribution data captures a critical difference in maturity: Injectable GLP-1 programs (Total 188): Phase 1 = 30%
GLP-1 receptor agonists can support glucose-dependent insulin release, reduce glucagon after meals, slow gastric emptying, and increase fullness
These adverse effects have led to numerous lawsuits against Novo Nordisk, alleging that the company failed to adequately warn users about the potential risks associated with Semaglutide
This requires risk-stratified prescription strategies targeting individuals with the greatest risk of complications or those most likely to benefit based on predictive biomarkers
It's not as fast, but you're less likely to experience side effects